Recent YSCC Discoveries

Publications regarding cancer attributed to first- and last-authors of published papers

Formerly called the Conclave Awards, the 2025 Spring Yale Cancer Center awards honored research, clinical expertise, and support staff at the Hotel Marcel, New Haven on April 1, 2025.

The American Association for the Advancement of Science has elected eight Yale faculty members as part of its latest class of fellows.

A new study from scientists at Yale School of Medicine has identified N-acetyltransferase 10 (NAT10), an enzyme highly expressed in brain metastasis, as a driver of brain metastasis. NAT10 primarily functions by adding acetyl groups to RNA molecules, regulating their function, stability or translation.

This Yale research, published in Science Signaling on March 25, offers new findings that could help improve therapies for glioblastoma and other aggressive cancers that are difficult to treat.

Yale scientists have developed a CRISPR technology that can assess genetic interactions on a host of immunological responses to multiple diseases, including cancer.

Twelve Yale School of Medicine faculty members are among the leading experts in science, technology, engineering, mathematics, and medicine newly elected to the Connecticut Academy of Science and Engineering.

Yale researchers take a deep dive into studies about hearing, nanowire assembly, heart imaging, photosynthesis, Tourette disorder, and AI in scientific writing.

Clemente Britto-Leon, MD, has been selected as the new director of the Pulmonary and Critical Care Fellowship in Yale School of Medicine’s Section of Pulmonary, Critical Care, and Sleep Medicine. He will assume the role on July 1, 2025.